6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide

CAS: 585543-15-3

Ref. 3D-FC102246

Produktinformation

• Name: 6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide
• Synonyme: Losmapimod, 3-Pyridinecarboxamide, 6-[5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-, 6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)nicotinamide, 6-[5-[(Cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-3-pyridinecarboxamide, Gsk-Ahab, Gw 856553, Gw 856553X, Gw856553, Sb 856553
• CAS: 585543-15-3

Beschreibung

6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide is a drug that inhibits cancer cell growth by inhibiting the production of natriuretic peptide levels. It also has been shown to be effective in preventing brain infarction and cardiac effects induced by an arterial occlusion. This drug has been shown to have a high risk of side effects, including weight gain, reduced heart rate, increased blood pressure, and increased cholesterol levels. 6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide also has the potential to interact with other drugs that are metabolized through the liver enzyme CYP 3A4 (such as simvastatin), which

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 383.46 g/mol
• Formel: C₂₂H₂₆FN₃O₂
• Reinheit: Min. 95%